01 1ACS Dobfar S.p.A
02 1Shandong Anhong Pharmaceutical Co., Ltd.
03 2Sumitomo Pharma Co., Ltd.
01 2MEROPENEM
02 1Meropenem
03 1Meropenem with sodium carbonate
01 1China
02 1Italy
03 2Japan
NDC Package Code : 52946-0839
Start Marketing Date : 2009-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49386-016
Start Marketing Date : 2014-12-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38217-0020
Start Marketing Date : 2018-07-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (12kg/12kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38217-0021
Start Marketing Date : 1996-09-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5kg/5.9kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
17
PharmaCompass offers a list of Meropenem API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Meropenem manufacturer or Meropenem supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Meropenem manufacturer or Meropenem supplier.
PharmaCompass also assists you with knowing the Meropenem API Price utilized in the formulation of products. Meropenem API Price is not always fixed or binding as the Meropenem Price is obtained through a variety of data sources. The Meropenem Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Meropenem, anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Meropenem, anhydrous, including repackagers and relabelers. The FDA regulates Meropenem, anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Meropenem, anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Meropenem, anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Meropenem, anhydrous supplier is an individual or a company that provides Meropenem, anhydrous active pharmaceutical ingredient (API) or Meropenem, anhydrous finished formulations upon request. The Meropenem, anhydrous suppliers may include Meropenem, anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of Meropenem, anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Meropenem, anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Meropenem, anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Meropenem, anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Meropenem, anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Meropenem, anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Meropenem, anhydrous suppliers with NDC on PharmaCompass.
We have 3 companies offering Meropenem, anhydrous
Get in contact with the supplier of your choice:
